GLP-1 S (5mg) x 30 Tablets

GLP-1 S (5mg) × 30 Tablets

This advanced single-compound tablet contains GLP-1 S, a peptide analogue studied for its potential role in metabolic regulation, appetite suppression, and glucose management. Formulated for investigators examining GLP-1 receptor activation and its downstream pathways, this compound provides a stable oral format optimized for preclinical studies on energy balance and insulin signaling.

Composition (Per Tablet):
GLP-1 S – 5mg
30 tablets per bottle

Key Characteristics:

• GLP-1 S: Investigated for its influence on GLP-1 receptor signaling, appetite modulation, and insulin sensitivity

• Supports studies focused on metabolic enhancement and energy expenditure

• Oral tablet format designed for compound stability and consistent delivery

• Controlled dosing suitable for reproducible preclinical applications

Intended Use:
This product is intended for laboratory research use only. It is not for human consumption, therapeutic use, or diagnostic purposes. Any application outside of approved research protocols is strictly prohibited.